These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
899 related items for PubMed ID: 17412489
21. Importance of peripheral biopsies in maximising the detection of early prostate cancer in repeat 12-core biopsy protocols. Philip J, Hanchanale V, Foster CS, Javlé P. BJU Int; 2006 Sep; 98(3):559-62. PubMed ID: 16925754 [Abstract] [Full Text] [Related]
22. Value of systematic transition zone biopsies in the early detection of prostate cancer. Bazinet M, Karakiewicz PI, Aprikian AG, Trudel C, Aronson S, Nachabé M, Péloquin F, Dessureault J, Goyal M, Zheng W, Bégin LR, Elhilali MM. J Urol; 1996 Feb; 155(2):605-6. PubMed ID: 8558670 [Abstract] [Full Text] [Related]
23. [Predictive value of prostate specific antigen density in the detection of prostate cancer in patients with elevated prostate specific antigen levels and normal digital rectal findings or stage A prostate cancer]. Iwaki H, Kajita Y, Shimizu Y, Yamauchi T. Hinyokika Kiyo; 2001 Mar; 47(3):169-74. PubMed ID: 11329957 [Abstract] [Full Text] [Related]
24. Optimizing prostate cancer detection: 8 versus 12-core biopsy protocol. de la Rosette JJ, Wink MH, Mamoulakis C, Wondergem N, ten Kate FJ, Zwinderman K, de Reijke TM, Wijkstra H. J Urol; 2009 Oct; 182(4):1329-36. PubMed ID: 19683269 [Abstract] [Full Text] [Related]
26. Cancer diagnosis with prostate specific antigen greater than 10 ng./ml. and negative peripheral zone prostate biopsy. Fowler JE, Condon MA, Terrell FL. J Urol; 1996 Oct; 156(4):1370-4. PubMed ID: 8808874 [Abstract] [Full Text] [Related]
27. Biopsy schemes with the fewest cores for detecting 95% of the prostate cancers detected by a 24-core biopsy. Scattoni V, Raber M, Abdollah F, Roscigno M, Dehò F, Angiolilli D, Maccagnano C, Gallina A, Capitanio U, Freschi M, Doglioni C, Rigatti P, Montorsi F. Eur Urol; 2010 Jan; 57(1):1-8. PubMed ID: 19720449 [Abstract] [Full Text] [Related]
28. Prostate biopsy: who, how and when. An update. Djavan B, Milani S, Remzi M. Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165 [Abstract] [Full Text] [Related]
29. Increasing prostate biopsy cores based on volume vs the sextant biopsy: a prospective randomized controlled clinical study on cancer detection rates and morbidity. Mariappan P, Chong WL, Sundram M, Mohamed SR. BJU Int; 2004 Aug; 94(3):307-10. PubMed ID: 15291857 [Abstract] [Full Text] [Related]
30. Predictors of prostate cancer on extended biopsy in patients with high-grade prostatic intraepithelial neoplasia: a multivariate analysis model. Abdel-Khalek M, El-Baz M, Ibrahiem el-H. BJU Int; 2004 Sep; 94(4):528-33. PubMed ID: 15329106 [Abstract] [Full Text] [Related]
31. [The clinical usefulness of routine biopsy of the transition zone in the diagnosis of prostate cancer]. Morote Robles J, López Pacios M, Encabo Duró G, de Torres Ramírez I. Actas Urol Esp; 1999 Sep; 23(7):583-6. PubMed ID: 10488612 [Abstract] [Full Text] [Related]
32. Detection of prostatic carcinoma: the role of TRUS, TRUS guided biopsy, digital rectal examination, PSA and PSA density. Men S, Cakar B, Conkbayir I, Hekimoglu B. J Exp Clin Cancer Res; 2001 Dec; 20(4):473-80. PubMed ID: 11876539 [Abstract] [Full Text] [Related]
33. No reason for immediate repeat sextant biopsy after negative initial sextant biopsy in men with PSA level of 4.0 ng/mL or greater (ERSPC, Rotterdam). Roobol MJ, van der Cruijsen IW, Schröder FH. Urology; 2004 May; 63(5):892-7; discussion 897-9. PubMed ID: 15134973 [Abstract] [Full Text] [Related]
34. Transrectal ultrasound-guided 10-core biopsy of the prostate for Japanese patients. Matsubara A, Mutaguchi K, Yasumoto H, Takeshima Y, Teishima J, Seki M, Hasegawa Y, Usui T. Hiroshima J Med Sci; 2006 Jun; 55(2):65-70. PubMed ID: 16813071 [Abstract] [Full Text] [Related]
35. [Biopsy technique and biopsy schemes for a first series of prostatic biopsies]. Villers A, Mouton D, Rébillard X, Chautard D, Ruffion A, Staerman F, Cornud F. Prog Urol; 2004 Apr; 14(2):144-53. PubMed ID: 15217126 [Abstract] [Full Text] [Related]
36. A prospective randomised trial of extended core prostate biopsy protocols utilizing 12 versus 15 cores. Rochester MA, Griffin S, Chappell B, McLoughlin J. Urol Int; 2009 Apr; 83(2):155-9. PubMed ID: 19752609 [Abstract] [Full Text] [Related]
38. Use of extended systematic sampling in patients with a prior negative prostate needle biopsy. Chon CH, Lai FC, McNeal JE, Presti JC. J Urol; 2002 Jun; 167(6):2457-60. PubMed ID: 11992057 [Abstract] [Full Text] [Related]
39. Detection rate of prostate cancer according to prostate-specific antigen and digital rectal examination in Korean men: a nationwide multicenter study. Seo HK, Chung MK, Ryu SB, Lee KH, Korean Urological Oncologic Society Prostate Cancer Study Group. Urology; 2007 Dec; 70(6):1109-12. PubMed ID: 18158028 [Abstract] [Full Text] [Related]
40. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer. Stamatiou K, Alevizos A, Karanasiou V, Mariolis A, Mihas C, Papathanasiou M, Bovis K, Sofras F. Urol Int; 2007 Dec; 78(4):313-7. PubMed ID: 17495488 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]